logo-loader
AIM:VAL

ValiRx PLC

Receive alerts
Market:
AIM
Price
0.15 GBX
Day Change
3.45%
Market Cap:
£1.98 m
52 weeks high
0.48
52 weeks low
0.12

In brief

ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health.

The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.